ADVANCED ENZYME TECH LTD
ADVENZYMES · General/Diversified · NSE
₹299
Current Market Price
Fair Value (DCF)
₹284
Margin of Safety
-5.0%
Updated 1d ago
YieldIQ Score
61/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
79%
ROE
—
Debt/Equity
0.02
WACC
11.1%
Market Cap
₹3,347 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
12.5%
Return on capital employed
EV / EBITDA
14.3×
Enterprise multiple
Debt / EBITDA
0.2×
Leverage vs earnings
Interest Coverage
53.6×
EBIT covers interest
Current Ratio
9.09×
Short-term liquidity
Asset Turnover
0.39×
Revenue per ₹ of assets
Revenue CAGR (3Y)
6.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹299.05
Bear case
₹155.38
MoS -92.5%
Base case
₹284.05
MoS -5.3%
Bull case
₹319.05
MoS +6.3%
Ratio Trends
ADVENZYMES · last 9 annual periods
ROE
8.9%
ROCE
15.1%
Operating Margin
—
Debt / Equity
0.03×
PE
80.9×
EV / EBITDA
14.1×
Historical Financials
ADVENZYMES · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹283 Cr | ₹529 Cr | ₹541 Cr | ₹624 Cr | ₹637 Cr | +22.4% |
| EBITDA | — | ₹208 Cr | ₹178 Cr | ₹226 Cr | ₹227 Cr | +2.3% |
| EBIT | ₹98.5 Cr | ₹173 Cr | ₹143 Cr | ₹191 Cr | — | +18.0% |
| PAT | ₹71.0 Cr | ₹124 Cr | ₹104 Cr | ₹137 Cr | ₹131 Cr | +16.6% |
| EPS (diluted) | ₹6.35 | ₹10.68 | ₹9.45 | ₹11.92 | — | +17.1% |
| CFO | ₹84.2 Cr | ₹124 Cr | ₹140 Cr | ₹141 Cr | ₹142 Cr | +14.1% |
| CapEx | — | — | — | — | ₹-34.8 Cr | — |
| FCF | — | — | — | — | ₹108 Cr | +0.0% |
| Total Assets | — | ₹1268 Cr | ₹1422 Cr | ₹1535 Cr | ₹1621 Cr | +6.3% |
| Total Debt | — | — | ₹5.4 Cr | ₹18.2 Cr | ₹39.4 Cr | +64.0% |
| Shareholders' Equity | — | — | ₹1235 Cr | ₹1324 Cr | ₹1469 Cr | +4.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ADVENZYMES vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BALAMINES BALAMINES | — | — | Pending | 7.8% | — |
| POCL POCL | — | — | Pending | 9.8% | — |
| VISHNU VISHNU CHEMICALS LIMITED | -43.0% | 47 | Above Fair Value | 13.7% | — |
| LXCHEM LXCHEM | — | — | Pending | 6.0% | — |
| TATVA TATVA | — | — | Pending | 0.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ADVENZYMES in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. ADVANCED ENZYME TECH LTD (ADVENZYMES.NS) trades at 299.05 vs a model fair value of 284.05, a gap of -5.0%. Piotroski F-score: 6/9. Moat l...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ADVENZYMES →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ADVENZYMES →
Compare
Head-to-head with peers
Compare ADVENZYMES side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ADVENZYMESNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.